Scientists have found that a protein named SIRT6 controls how the amino acid tryptophan works in the brain. This protein decides if tryptophan turns into helpful chemicals that support mood, sleep, and energy or into harmful ones that damage brain cells. The work comes from lab tests on cells, fruit flies, and mice, showing what happens when SIRT6 levels drop with age or illness.
Background
Tryptophan is an amino acid we get from food like turkey, eggs, and cheese. The body needs it to build proteins, but in the brain, it does more. It serves as the starting point for key chemicals. One path leads to serotonin, which helps control mood and sleep. Another makes melatonin for rest. Tryptophan also feeds into energy production through a process that creates NAD, a molecule cells use for fuel.
Most tryptophan, about 95 percent, follows a different route called the kynurenine pathway. This path makes compounds that can protect or hurt the brain. Some, like kynurenic acid, block overactive signals between nerve cells. Others, like quinolinic acid, act like excitotoxins that overstimulate and kill cells. Balance matters. Stress, infection, or inflammation can push more tryptophan this way by turning on enzymes like TDO2 and IDO.
The brain gets tryptophan from blood, where it binds to albumin or floats free. Stress raises free levels by changing fats in blood, letting more enter the brain. There, enzymes decide its fate. TPH2 turns it into serotonin, but only a small share goes that way. TPH2 needs steady tryptophan supply, and its activity sets the pace. Gut bacteria also break down tryptophan into indoles that reach the brain and affect growth and immunity.
This system keeps the brain steady during growth and daily life. But as people age, things shift. Diseases like Alzheimer's or Parkinson's mess it up more. Low serotonin links to depression and sleep trouble. Toxic kynurenines tie to memory loss and mood swings.
Key Details
Researchers looked at SIRT6, a protein that helps control genes and metabolism. It keeps tabs on enzymes that steer tryptophan. In tests, they saw SIRT6 binds to genes for TDO2, which starts the kynurenine path, and AANAT, which helps make melatonin.
When SIRT6 drops, control slips. TDO2 ramps up, sending tryptophan to kynurenines. This makes neurotoxic compounds rise while serotonin and melatonin fall. Cells showed gene changes. Fruit flies with less SIRT6 had brain issues like poor memory and odd sleep. Mice mirrored this, with weaker mood responses and energy dips.
How the Paths Work
Take TPH2. This enzyme sits only in brain cells that make serotonin, mainly in the raphe area of the hindbrain. It grabs tryptophan and makes 5-HTP, then serotonin fast. TPH2 works best at normal brain tryptophan levels, so food or blood changes hit it hard. TPH1 does similar work in the gut.
The kynurenine path starts with TDO2 or IDO. Stress hormones like cortisol boost TDO2. Infections fire up IDO with cytokines. Kynurenine crosses into the brain easily. There, it splits: to kynurenic acid, which calms NMDA receptors, or quinolinic acid, which fires them up and sparks damage.
Diet plays a role. More tryptophan calms aggression and cuts stress hormones in animals. It boosts brain growth factors like BDNF. But too much kynurenine path use starves serotonin making.
"SIRT6 actively controls gene expression for key enzymes like TDO2 and AANAT. When it drops, tryptophan shifts to harmful kynurenines while protective serotonin and melatonin decline." – Lead researcher on the study
Labs confirmed this in live models. Flies lived shorter with low SIRT6 and showed learning gaps. Mice had less brain serotonin and more toxins after aging or disease mimics.
What This Means
This finding points to SIRT6 as a switch for brain health. In aging, natural SIRT6 loss could explain why older people face memory fog, bad sleep, and low mood. Diseases speed this by stressing cells and raising inflammation, which worsens the shift.
For neurodevelopment, tryptophan balance shapes brain wiring. Gut bugs and mom’s diet affect it early, linking to autism or ADHD risks if off. Fixing paths might help kids with these issues.
Treatment ideas follow. Boosting SIRT6 could pull tryptophan back to safe routes. Drugs targeting TPH2 activators exist in early tests. Diet tweaks, like steady tryptophan without excess stress, might aid. In stress or infection, blocking IDO could save serotonin.
Animal studies show promise. Rats with extra dietary tryptophan grew more brain cells. Fish and birds react similar, hinting broad effects. Human trials lag, but depression treatments already use tryptophan boosts.
Everyday angle: Sleep aids push tryptophan for serotonin. But if SIRT6 falters, it might backfire to toxins. Aging brains need checks on this protein.
Broader view ties to immunity. Kynurenines calm inflammation but overdo it harms. Cancer or infections hijack the path, starving brain serotonin.
Work continues at events like the 2026 ISTRY meeting, where experts swap notes on tryptophan roles in brain, immunity, and age. Findings could lead to tests measuring SIRT6 or paths in blood for early disease spots.
Patients with Parkinson's lose serotonin neurons early. Alzheimer's has kynurenine spikes. Targeting SIRT6 might slow both. Sleep disorders from low melatonin could improve too.
Field grows fast. New tools image TPH2 structure for precise drugs. Gut-brain links open probiotic paths to fix indoles.
